Cargando…
Lack of Tumorigenicity of Aminopyrine Orally Administered to B6C3F(1) Mice
To test the tumorigenic potential of aminopyrine, an antipyretic analgesic, it was administered in drinking water at levels of 0 (control), 0.04 and 0.08% to 50 male and 50 female B6C3F(1), mice for 100 weeks, and the mice were subsequently maintained without aminopyrine for a further 4 weeks. The m...
Autores principales: | Inai, Kouki, Kobuke, Toshihiro, Fujihara, Megumu, Yonehara, Shuji, Takemoto, Tsuyoshi, Tsuya, Takafumi, Yamamoto, Atsushi, Tachiyama, Yoshiro, Izumi, Kumiko, Tokuoka, Shoji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963906/ https://www.ncbi.nlm.nih.gov/pubmed/2110128 http://dx.doi.org/10.1111/j.1349-7006.1990.tb02537.x |
Ejemplares similares
-
Hepatocellular Tumorigenicity of Butylated Hydroxytoluene Administered Orally to B6C3F(1) Mice
por: Inai, Kouki, et al.
Publicado: (1988) -
Quantitative Risk Assessment of Carcinogenicity of Urethane (Ethyl Carbamatc) on the Basis of Long‐term Oral Administration to B6C3F(1) Mice
por: Inai, Kouki, et al.
Publicado: (1991) -
Role of Point Mutation of the K‐ras Gene in Tumorigenesis of B6C3F(1) Mouse Lung Lesions Induced by Urethane
por: Kawano, Ryoji, et al.
Publicado: (1995) -
In vivo effects of Faizol Ubat Batuk, a herbal product on aminopyrine metabolism in rat hepatocytes
por: Taher, Yousef A., et al.
Publicado: (2011) -
Characteristics of Benign and Malignant Bone Tumors Registered in the Hiroshima Tumor Tissue Registry, 1973-2012
por: Sugiyama, Hiromi, et al.
Publicado: (2018)